CCP5 activators are a distinct class of chemical entities designed to enhance the enzymatic function of Cysteinyl Cathepsin Protease 5 (CCP5). CCP5 is part of the cathepsin family of proteases, which are largely lysosomal enzymes involved in protein degradation and turnover. Unlike inhibitors, which aim to reduce the proteolytic activity of these enzymes, activators work to increase their catalytic efficiency. The regulation of CCP5 activity is crucial for maintaining proper protein degradation pathways within the lysosome, and activators may be utilized to modulate this process. The exact mechanism of action for CCP5 activators can vary, but generally involves either direct interaction with the enzyme to promote its active conformation or indirectly enhancing its expression or stabilization within the cellular environment.
The design of CCP5 activators requires a sophisticated understanding of the enzyme's structure and the allosteric sites that can be targeted to upregulate its proteolytic activity. These activators may bind to regions of the enzyme distinct from the active site, inducing conformational changes that result in an increased affinity for substrate or a higher turnover rate. The molecular architecture of these compounds is typically based on insights gained from detailed biochemical assays, crystallography, and computational modeling that shed light on the dynamics of enzyme activation. Researchers often employ iterative cycles of design and testing to refine the activator molecules, ensuring that they are both potent and specific to CCP5. This refinement process is guided by the measurement of changes in enzymatic activity through various in vitro assays, which can quantify the extent to which these activators are able to enhance the function of CCP5.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
May upregulate CCP5 as it is critical in cellular differentiation, which could necessitate changes in tubulin deglutamylation to support altered cytoskeletal dynamics. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Could stimulate CCP5 expression due to its antioxidative properties, potentially initiating a cellular response to maintain microtubule integrity via tubulin deglutamylation. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Might induce CCP5 expression through activation of Wnt signaling pathway, which is known to play a role in the development and regulation of the cytoskeleton. | ||||||
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $41.00 $74.00 $221.00 $247.00 $738.00 $1220.00 | 39 | |
By stabilizing microtubules, Taxol may trigger a compensatory increase in CCP5 expression to balance tubulin glutamylation levels within the cell. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
The disruption of microtubule polymerization by nocodazole may necessitate an upsurge in CCP5 expression to address the sudden change in microtubule dynamics. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
May stimulate CCP5 expression through activation of sirtuin pathways, which are involved in the regulation of cellular processes including those governing cytoskeletal organization. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Could induce CCP5 expression by promoting histone hyperacetylation, which can lead to the transcriptional activation of genes, including those encoding proteins like CCP5. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
May increase CCP5 expression by facilitating chromatin decompaction, making the AGBL5 gene more accessible to the transcriptional machinery. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
Could upregulate CCP5 by reducing DNA methylation near the AGBL5 gene promoter, thereby enhancing transcriptional activity for CCP5 production. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
May lead to an upsurge in CCP5 expression due to its role as an HDAC inhibitor, which could result in an open chromatin state around the AGBL5 gene. | ||||||